Gland Pharmas Q2FY22 revenue rises 30% with net profit growth of 38%
As on September 30, 2021, the Company along with its Partners have filed total 291 ANDAs, out of which 244 were approved and 47 are pending approval.
from India Infoline News Service https://ift.tt/3pzByc4
from India Infoline News Service https://ift.tt/3pzByc4
Comments